Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study. [electronic resource]
Producer: 20030321Description: 20-5 p. digitalISSN:- 0735-1097
- Adult
- Angioplasty, Balloon, Coronary -- adverse effects
- Anticoagulants -- adverse effects
- Coronary Angiography -- adverse effects
- Drug Therapy, Combination
- Enoxaparin -- adverse effects
- Eptifibatide
- Equipment and Supplies -- adverse effects
- Female
- Hemorrhage -- epidemiology
- Heparin -- therapeutic use
- Humans
- Male
- Middle Aged
- Peptides -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Stents
- Suture Techniques -- adverse effects
- Treatment Outcome
- Vascular Diseases -- epidemiology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.